PRESS RELEASE
View printer-friendly version << Back
WNS Positioned in the ‘Winner’s Circle’ in the HfS Blueprint Report for Pharmaceuticals Industry-specific BPO
“WNS is thrilled to be recognized as a 'Winner' in the categories of
execution and innovation by HfS. Our deep domain expertise,
collaborative approach and analytics capabilities have been instrumental
in driving our strategic positioning in the Pharma industry. This
recognition is a testimony to the investments we have been making in
future ready technologies and talent,” said
WNS combines industry best practices and proprietary tools and methodologies to improve end-client satisfaction and reduce operational costs, while streamlining processes through continuous improvements and technology optimization. WNS has over 2,000 professionals with backgrounds in Pharma and Healthcare, including pharmacists, doctors, certified clinical specialists, researchers and analytics professionals.
This HfS Research Blueprint: Pharmaceuticals Industry-Specific BPO Blueprint, looks at the evolution of Pharma BPO to “As-a-Service”—a market that is increasingly agile, collaborative, and consumer-centric. HfS considers this transition in outsourcing a move to the As-a-Service Economy, placing increasing value on diverse talent, analytics, and collaboration, as well as increasingly on platform-based services. The report includes a comparative analysis of the innovation and execution capabilities of service providers in this market. The service providers in scope are multi-national, multi-functional service providers with industry-specific pharmaceuticals business process support capability in their portfolio.
About WNS
Safe Harbor Provision
This document includes information which may constitute forward-looking
statements made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995, the accuracy of which are
necessarily subject to risks, uncertainties, and assumptions as to
future events. Factors that could cause actual results to differ
materially from those expressed or implied are discussed in our most
recent Form 20-F and other filings with the
View source version on businesswire.com: http://www.businesswire.com/news/home/20160215005236/en/
Source:
WNS (Holdings) Limited
Investors:
David
Mackey
Corporate SVP - Finance & Head of Investor Relations
+1
(201) 942-6261
david.mackey@wns.com
or
Media:
Archana
Raghuram
Head – Corporate Communications
+91 (22) 4095 2397
archana.raghuram@wns.com;
pr@wns.com